<DOC>
	<DOCNO>NCT02500511</DOCNO>
	<brief_summary>To determine persistence protective antibody level subject seroconverted vaccination NmVac4-A/C/Y/W-135-DT™ Participants trial # JN-NM-002 , seroconverted serogroups A C contact ask provide blood sample 12-24 month vaccination NmVac4-A/C/Y/W-135-DT . Serum Bactericidal Assays perform evaluated duration protective antibody titer NmVac4-A/C/Y/W-135-DT four serogroups . To determine subject seroconverted low titer retain protective level antibody ( titer ≥:8 ) 12-24 month vaccination .</brief_summary>
	<brief_title>Persistence Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination : Follow Up Study</brief_title>
	<detailed_description>The purpose study collect serum sample evaluate duration protection NmVac4-A/C/Y/W-135-DT , base titer determine Serum Bactericidal Assay human complement ( hSBA ) . This assay use evaluate immunogenicity meningococcal vaccine , surrogate efficacy . A titer ≥ 1:8 consider protective . Objectives evaluate duration protective antibody titer NmVac4-A/C/Y/W-135-DT four serogroups , determine subject low titer , ≥:8 retain protective level antibody 12-24 month . Participants trial # JN-NM-002 , seroconverted serogroups A C contact ask provide blood sample 12-24 month vaccination NmVac4-A/C/Y/W-135-DT™ . Serum Bactericidal Assays perform evaluated persistence protective antibody titer NmVac4-A/C/Y/W-135-DT four serogroups , determine subject seroconverted low titer retain protective level antibody ( titer ≥:8 ) 12-24 month vaccination .</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Willing able give inform consent Participant trial JNNM002 Seroconverted trial JNNM002 serogroups A C Chronic medication use medical history , opinion Investigator , may impact quality sample safety subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>